ReP USP - Resultado da busca

Artigo de periodico
Bioresponsive nanostructured systems for sustained naltrexone release and treatment of alcohol use disorder: development and biological evaluation (2020)
Santos, Rogério Aparecido dos; Rae, Mariana Beu ; Dartora, Vanessa Franco Carvalho ; Matos, Jenyffer Kelly Rocha de ; Camarini, Rosana ; Lopes, Luciana Biagini
Source: International Journal of Pharmaceutics. Unidade: ICB
Subjects: FARMACOLOGIA, ALCOOLISMO, TRANSTORNOS RELACIONADOS AO USO DE ÁLCOOL, DEPENDENTES QUÍMICOS, ANTAGONISTAS, FÁRMACOS (SISTEMA NERVOSO PERIFÉRICO), ANTAGONISMO DE DROGAS, CINÉTICA DOS LÍQUIDOS, ETANOL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Rogério Aparecido dos; RAE, Mariana Beu; DARTORA, Vanessa Franco Carvalho; et al. Bioresponsive nanostructured systems for sustained naltrexone release and treatment of alcohol use disorder: development and biological evaluation. International Journal of Pharmaceutics, Amsterdam, Elsevier BV, v. 585, p. 12 , 2020. Disponível em: < https://doi.org/10.1016/j.ijpharm.2020.119474 > DOI: 10.1016/j.ijpharm.2020.119474.
APA
Santos, R. A. dos, Rae, M. B., Dartora, V. F. C., Matos, J. K. R. de, Camarini, R., & Lopes, L. B. (2020). Bioresponsive nanostructured systems for sustained naltrexone release and treatment of alcohol use disorder: development and biological evaluation. International Journal of Pharmaceutics, 585, 12 . doi:10.1016/j.ijpharm.2020.119474
NLM
Santos RA dos, Rae MB, Dartora VFC, Matos JKR de, Camarini R, Lopes LB. Bioresponsive nanostructured systems for sustained naltrexone release and treatment of alcohol use disorder: development and biological evaluation [Internet]. International Journal of Pharmaceutics. 2020 ; 585 12 .Available from: https://doi.org/10.1016/j.ijpharm.2020.119474
Vancouver
Santos RA dos, Rae MB, Dartora VFC, Matos JKR de, Camarini R, Lopes LB. Bioresponsive nanostructured systems for sustained naltrexone release and treatment of alcohol use disorder: development and biological evaluation [Internet]. International Journal of Pharmaceutics. 2020 ; 585 12 .Available from: https://doi.org/10.1016/j.ijpharm.2020.119474
Artigo de periodico
Identification of approved drugs as potent inhibitors of pregnane X receptor activation with differential receptor interaction profiles (2018)
Burk, Oliver; Kuzikov, Maria; Kronenberger, Thales ; Jeske, Judith; Keminer, Oliver ; Thasler, Wolfgang E. ; Schwab, Matthias ; Wrenger, Carsten ; Windshügel, Bjorn
Source: Archives of Toxicology. Unidade: ICB
Subjects: PARASITOLOGIA, ANTAGONISMO DE DROGAS, CÉLULAS KUPFFER
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BURK, Oliver; KUZIKOV, Maria; KRONENBERGER, Thales; et al. Identification of approved drugs as potent inhibitors of pregnane X receptor activation with differential receptor interaction profiles. Archives of Toxicology, Heidelberg, Springer, v. 92, p. 1435-1451, 2018. Disponível em: < https://doi.org/10.1007/s00204-018-2165-4 > DOI: 10.1007/s00204-018-2165-4.
APA
Burk, O., Kuzikov, M., Kronenberger, T., Jeske, J., Keminer, O., Thasler, W. E. , et al. (2018). Identification of approved drugs as potent inhibitors of pregnane X receptor activation with differential receptor interaction profiles. Archives of Toxicology, 92, 1435-1451. doi:10.1007/s00204-018-2165-4
NLM
Burk O, Kuzikov M, Kronenberger T, Jeske J, Keminer O, Thasler W E , Schwab M, Wrenger C, Windshügel B. Identification of approved drugs as potent inhibitors of pregnane X receptor activation with differential receptor interaction profiles [Internet]. Archives of Toxicology. 2018 ; 92 1435-1451.Available from: https://doi.org/10.1007/s00204-018-2165-4
Vancouver
Burk O, Kuzikov M, Kronenberger T, Jeske J, Keminer O, Thasler W E , Schwab M, Wrenger C, Windshügel B. Identification of approved drugs as potent inhibitors of pregnane X receptor activation with differential receptor interaction profiles [Internet]. Archives of Toxicology. 2018 ; 92 1435-1451.Available from: https://doi.org/10.1007/s00204-018-2165-4
Artigo de periodico
Chemical interaction of endophytic fungi and actinobacteria from Lychnophora ericoides in co-cultures (2018)
Chagas, Fernanda O.; Pupo, Mônica Tallarico
Source: Microbiological Research. Unidade: FCFRP
Subjects: ANTAGONISMO DE DROGAS, COMUNICAÇÃO QUÍMICA ANIMAL, ASCOMYCOTA, COMPOSITAE, FUNGOS, STREPTOMYCES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHAGAS, Fernanda O.; PUPO, Mônica Tallarico. Chemical interaction of endophytic fungi and actinobacteria from Lychnophora ericoides in co-cultures. Microbiological Research, Jena, v. 212-213, p. 10-16, 2018. Disponível em: < http://dx.doi.org/10.1016/j.micres.2018.04.005 > DOI: 10.1016/j.micres.2018.04.005.
APA
Chagas, F. O., & Pupo, M. T. (2018). Chemical interaction of endophytic fungi and actinobacteria from Lychnophora ericoides in co-cultures. Microbiological Research, 212-213, 10-16. doi:10.1016/j.micres.2018.04.005
NLM
Chagas FO, Pupo MT. Chemical interaction of endophytic fungi and actinobacteria from Lychnophora ericoides in co-cultures [Internet]. Microbiological Research. 2018 ; 212-213 10-16.Available from: http://dx.doi.org/10.1016/j.micres.2018.04.005
Vancouver
Chagas FO, Pupo MT. Chemical interaction of endophytic fungi and actinobacteria from Lychnophora ericoides in co-cultures [Internet]. Microbiological Research. 2018 ; 212-213 10-16.Available from: http://dx.doi.org/10.1016/j.micres.2018.04.005
Artigo de periodico
Wheel running during chronic nicotine exposure is protective against mecamylamine-precipitated withdrawal and up-regulates hippocampal alfa7 nAch receptors in mice (2018)
Keyworth, Helen ; Georgiou, Polymnia ; Zanos, Panos ; Rueda, André Veloso; Chen, Ying; Kitchen, Ian; Cropley, Mark ; Bailey, Alexis ; Camarini, Rosana
Source: British Journal of Pharmacology. Unidade: ICB
Subjects: FÁRMACOS (SISTEMA NERVOSO CENTRAL), FÁRMACOS PSICOTRÓPICOS, CAMUNDONGOS, MODELOS ANIMAIS, HIPOCAMPU DE ANIMAL, ANTAGONISMO DE DROGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KEYWORTH, Helen; GEORGIOU, Polymnia; ZANOS, Panos; et al. Wheel running during chronic nicotine exposure is protective against mecamylamine-precipitated withdrawal and up-regulates hippocampal alfa7 nAch receptors in mice. British Journal of Pharmacology, Oxford, John Wiley & Sons Ltd., v. 175, p. 1928-1943, 2018. DOI: 10.1111/bph.14068.
APA
Keyworth, H., Georgiou, P., Zanos, P., Rueda, A. V., Chen, Y., Kitchen, I., et al. (2018). Wheel running during chronic nicotine exposure is protective against mecamylamine-precipitated withdrawal and up-regulates hippocampal alfa7 nAch receptors in mice. British Journal of Pharmacology, 175, 1928-1943. doi:10.1111/bph.14068
NLM
Keyworth H, Georgiou P, Zanos P, Rueda AV, Chen Y, Kitchen I, Cropley M, Bailey A, Camarini R. Wheel running during chronic nicotine exposure is protective against mecamylamine-precipitated withdrawal and up-regulates hippocampal alfa7 nAch receptors in mice. British Journal of Pharmacology. 2018 ; 175 1928-1943.
Vancouver
Keyworth H, Georgiou P, Zanos P, Rueda AV, Chen Y, Kitchen I, Cropley M, Bailey A, Camarini R. Wheel running during chronic nicotine exposure is protective against mecamylamine-precipitated withdrawal and up-regulates hippocampal alfa7 nAch receptors in mice. British Journal of Pharmacology. 2018 ; 175 1928-1943.
Tese
Avaliação das vias envolvidas no efeito do antagonismo da ouabaína endógena sobre o remodelamento de artérias mesentéricas de resistência de ratos com hipertensão DOCA-sal (2018)
Tomazelli, Caroline Aparecida; Rossoni, Luciana Venturini (Orientador)
Unidade: ICB
Subjects: HIPERTENSÃO, FÁRMACOS (SISTEMA CARDIOVASCULAR), PRESSÃO SANGUÍNEA, VASOS CORONÁRIOS, ANTAGONISMO DE DROGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOMAZELLI, Caroline Aparecida; ROSSONI, Luciana Venturini. Avaliação das vias envolvidas no efeito do antagonismo da ouabaína endógena sobre o remodelamento de artérias mesentéricas de resistência de ratos com hipertensão DOCA-sal. 2018.Universidade de São Paulo, São Paulo, 2018. Disponível em: < http://www.teses.usp.br/teses/disponiveis/42/42137/tde-11022019-110721/ >.
APA
Tomazelli, C. A., & Rossoni, L. V. (2018). Avaliação das vias envolvidas no efeito do antagonismo da ouabaína endógena sobre o remodelamento de artérias mesentéricas de resistência de ratos com hipertensão DOCA-sal. Universidade de São Paulo, São Paulo. Recuperado de http://www.teses.usp.br/teses/disponiveis/42/42137/tde-11022019-110721/
NLM
Tomazelli CA, Rossoni LV. Avaliação das vias envolvidas no efeito do antagonismo da ouabaína endógena sobre o remodelamento de artérias mesentéricas de resistência de ratos com hipertensão DOCA-sal [Internet]. 2018 ;Available from: http://www.teses.usp.br/teses/disponiveis/42/42137/tde-11022019-110721/
Vancouver
Tomazelli CA, Rossoni LV. Avaliação das vias envolvidas no efeito do antagonismo da ouabaína endógena sobre o remodelamento de artérias mesentéricas de resistência de ratos com hipertensão DOCA-sal [Internet]. 2018 ;Available from: http://www.teses.usp.br/teses/disponiveis/42/42137/tde-11022019-110721/
Artigo de periodico
Population pharmacokinetics of carvedilol enantiomers and their metabolites in healthy subjects and type-2 diabetes patients (2017)
Nardotto, Glauco H. B; Lanchote, Vera Lúcia; Coelho, Eduardo Barbosa; Della Pasqua, Oscar
Source: European Journal of Pharmaceutical Sciences. Unidades: FCFRP, FMRP
Subjects: FARMACOLOGIA, DIABETES MELLITUS, ANTAGONISMO DE DROGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NARDOTTO, Glauco H. B; LANCHOTE, Vera Lúcia; COELHO, Eduardo Barbosa; DELLA PASQUA, Oscar. Population pharmacokinetics of carvedilol enantiomers and their metabolites in healthy subjects and type-2 diabetes patients. European Journal of Pharmaceutical Sciences, Amsterdam, v. 109S, p. S108-S115, 2017. Disponível em: < http://dx.doi.org/10.1016/j.ejps.2017.05.033 > DOI: 10.1016/j.ejps.2017.05.033.
APA
Nardotto, G. H. B., Lanchote, V. L., Coelho, E. B., & Della Pasqua, O. (2017). Population pharmacokinetics of carvedilol enantiomers and their metabolites in healthy subjects and type-2 diabetes patients. European Journal of Pharmaceutical Sciences, 109S, S108-S115. doi:10.1016/j.ejps.2017.05.033
NLM
Nardotto GHB, Lanchote VL, Coelho EB, Della Pasqua O. Population pharmacokinetics of carvedilol enantiomers and their metabolites in healthy subjects and type-2 diabetes patients [Internet]. European Journal of Pharmaceutical Sciences. 2017 ; 109S S108-S115.Available from: http://dx.doi.org/10.1016/j.ejps.2017.05.033
Vancouver
Nardotto GHB, Lanchote VL, Coelho EB, Della Pasqua O. Population pharmacokinetics of carvedilol enantiomers and their metabolites in healthy subjects and type-2 diabetes patients [Internet]. European Journal of Pharmaceutical Sciences. 2017 ; 109S S108-S115.Available from: http://dx.doi.org/10.1016/j.ejps.2017.05.033
Trabalho de evento-resumo periodico
Development of an HPLC method for quantification of amlodipine in pharmaceutical dosage form (2017)
Ichinose, Livia dos Santos; Lazaro, Lourdes Marcela Yataco; Kedor-Hackmann, Erika Rosa Maria; Santoro, Maria Inês Rocha Miritello; Aurora-Prado, Maria Segunda
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
Subjects: CROMATOGRAFIA LÍQUIDA DE ALTA EFICIÊNCIA, ANTAGONISMO DE DROGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ICHINOSE, Livia dos Santos; LAZARO, Lourdes Marcela Yataco; KEDOR-HACKMANN, Erika Rosa Maria; SANTORO, Maria Inês Rocha Miritello; AURORA-PRADO, Maria Segunda. Development of an HPLC method for quantification of amlodipine in pharmaceutical dosage form. Brazilian Journal of Pharmaceutical Sciences[S.l: s.n.], 2017.
APA
Ichinose, L. dos S., Lazaro, L. M. Y., Kedor-Hackmann, E. R. M., Santoro, M. I. R. M., & Aurora-Prado, M. S. (2017). Development of an HPLC method for quantification of amlodipine in pharmaceutical dosage form. Brazilian Journal of Pharmaceutical Sciences. São Paulo.
NLM
Ichinose L dos S, Lazaro LMY, Kedor-Hackmann ERM, Santoro MIRM, Aurora-Prado MS. Development of an HPLC method for quantification of amlodipine in pharmaceutical dosage form. Brazilian Journal of Pharmaceutical Sciences. 2017 ; 53 60 res. FCF115.
Vancouver
Ichinose L dos S, Lazaro LMY, Kedor-Hackmann ERM, Santoro MIRM, Aurora-Prado MS. Development of an HPLC method for quantification of amlodipine in pharmaceutical dosage form. Brazilian Journal of Pharmaceutical Sciences. 2017 ; 53 60 res. FCF115.
Tese
Desenvolvimento de microemulsões e sua transformação in situ em géis de fase líquido-cristalina como plataforma para liberação sustentada de fármacos e seu uso no tratamento do alcoolismo (2017)
Santos, Rogério Aparecido dos; Camarini, Rosana (Orientador); Lopes, Luciana Biagini (Orientador)
Unidade: ICB
Subjects: ALCOOLISMO, CAMUNDONGOS, ANTAGONISMO DE DROGAS, ÓPIO, MORFINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Rogério Aparecido dos; CAMARINI, Rosana; LOPES, Luciana Biagini. Desenvolvimento de microemulsões e sua transformação in situ em géis de fase líquido-cristalina como plataforma para liberação sustentada de fármacos e seu uso no tratamento do alcoolismo. 2017.Universidade de São Paulo, São Paulo, 2017. Disponível em: < http://www.teses.usp.br/teses/disponiveis/42/42136/tde-14032018-155109/ >.
APA
Santos, R. A. dos, Camarini, R., & Lopes, L. B. (2017). Desenvolvimento de microemulsões e sua transformação in situ em géis de fase líquido-cristalina como plataforma para liberação sustentada de fármacos e seu uso no tratamento do alcoolismo. Universidade de São Paulo, São Paulo. Recuperado de http://www.teses.usp.br/teses/disponiveis/42/42136/tde-14032018-155109/
NLM
Santos RA dos, Camarini R, Lopes LB. Desenvolvimento de microemulsões e sua transformação in situ em géis de fase líquido-cristalina como plataforma para liberação sustentada de fármacos e seu uso no tratamento do alcoolismo [Internet]. 2017 ;Available from: http://www.teses.usp.br/teses/disponiveis/42/42136/tde-14032018-155109/
Vancouver
Santos RA dos, Camarini R, Lopes LB. Desenvolvimento de microemulsões e sua transformação in situ em géis de fase líquido-cristalina como plataforma para liberação sustentada de fármacos e seu uso no tratamento do alcoolismo [Internet]. 2017 ;Available from: http://www.teses.usp.br/teses/disponiveis/42/42136/tde-14032018-155109/
Artigo de periodico
5-Hydroxytryptamine 1A receptors in the dorsomedial hypothalamus connected to dorsal raphe nucleus inputs modulate defensive behaviours and mediate innate fear-induced antinociception (2016)
Biagioni, Audrey Franceschi; Oliveira, Rithiele Cristina de; Oliveira, Ricardo de; Silva, Juliana Almeida da; Anjos-Garcia, Tayllon dos; Roncon, Camila Marroni; Corrado, Alexandre Pinto; Zangrossi Júnior, Hélio; Coimbra, Norberto Cysne
Source: European Neuropsychopharmacology. Unidade: FMRP
Subjects: HIPOTÁLAMO, ANTAGONISMO DE DROGAS, GABA, MEDO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BIAGIONI, Audrey Franceschi; OLIVEIRA, Rithiele Cristina de; OLIVEIRA, Ricardo de; et al. 5-Hydroxytryptamine 1A receptors in the dorsomedial hypothalamus connected to dorsal raphe nucleus inputs modulate defensive behaviours and mediate innate fear-induced antinociception. European Neuropsychopharmacology, Amsterdam, v. 26, n. 3, p. 532-545, 2016. Disponível em: < http://dx.doi.org/10.1016/j.euroneuro.2015.12.032 > DOI: 10.1016/j.euroneuro.2015.12.032.
APA
Biagioni, A. F., Oliveira, R. C. de, Oliveira, R. de, Silva, J. A. da, Anjos-Garcia, T. dos, Roncon, C. M., et al. (2016). 5-Hydroxytryptamine 1A receptors in the dorsomedial hypothalamus connected to dorsal raphe nucleus inputs modulate defensive behaviours and mediate innate fear-induced antinociception. European Neuropsychopharmacology, 26( 3), 532-545. doi:10.1016/j.euroneuro.2015.12.032
NLM
Biagioni AF, Oliveira RC de, Oliveira R de, Silva JA da, Anjos-Garcia T dos, Roncon CM, Corrado AP, Zangrossi Júnior H, Coimbra NC. 5-Hydroxytryptamine 1A receptors in the dorsomedial hypothalamus connected to dorsal raphe nucleus inputs modulate defensive behaviours and mediate innate fear-induced antinociception [Internet]. European Neuropsychopharmacology. 2016 ; 26( 3): 532-545.Available from: http://dx.doi.org/10.1016/j.euroneuro.2015.12.032
Vancouver
Biagioni AF, Oliveira RC de, Oliveira R de, Silva JA da, Anjos-Garcia T dos, Roncon CM, Corrado AP, Zangrossi Júnior H, Coimbra NC. 5-Hydroxytryptamine 1A receptors in the dorsomedial hypothalamus connected to dorsal raphe nucleus inputs modulate defensive behaviours and mediate innate fear-induced antinociception [Internet]. European Neuropsychopharmacology. 2016 ; 26( 3): 532-545.Available from: http://dx.doi.org/10.1016/j.euroneuro.2015.12.032
Artigo de periodico
Should patients with cardiovascular risk factors receive intensive treatment of hypertension to <120/80 mm Hg target? (2016)
Lonn, Eva M.; Yusuf, Salim; Marin Neto, José Antonio
Source: Circulation. Unidade: FMRP
Subjects: FÁRMACOS (SISTEMA CARDIOVASCULAR), HIPERTENSÃO, FATORES DE RISCO, ANTAGONISMO DE DROGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LONN, Eva M.; YUSUF, Salim; MARIN NETO, José Antonio. Should patients with cardiovascular risk factors receive intensive treatment of hypertension to <120/80 mm Hg target? Circulation, Philadelphia, v. 134, n. 18, p. 1311-1313, 2016. Disponível em: < http://dx.doi.org/10.1161/circulationaha.116.023264 > DOI: 10.1161/circulationaha.116.023264.
APA
Lonn, E. M., Yusuf, S., & Marin Neto, J. A. (2016). Should patients with cardiovascular risk factors receive intensive treatment of hypertension to <120/80 mm Hg target? Circulation, 134( 18), 1311-1313. doi:10.1161/circulationaha.116.023264
NLM
Lonn EM, Yusuf S, Marin Neto JA. Should patients with cardiovascular risk factors receive intensive treatment of hypertension to<120/80 mm Hg target? [Internet]. Circulation. 2016 ; 134( 18): 1311-1313.Available from: http://dx.doi.org/10.1161/circulationaha.116.023264
Vancouver
Lonn EM, Yusuf S, Marin Neto JA. Should patients with cardiovascular risk factors receive intensive treatment of hypertension to<120/80 mm Hg target? [Internet]. Circulation. 2016 ; 134( 18): 1311-1313.Available from: http://dx.doi.org/10.1161/circulationaha.116.023264
Artigo de periodico
HIV-1 Nef: taking control of protein trafficking (2016)
Pereira, Estela A.; Silva, Luis Lamberti Pinto da
Source: Traffic. Unidade: FMRP
Subjects: HIV, PROTEÍNAS, ANTÍGENOS DE VÍRUS, LISOSSOMOS, ANTAGONISMO DE DROGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Estela A.; SILVA, Luis Lamberti Pinto da. HIV-1 Nef: taking control of protein trafficking. Traffic, West Sussex, v. 17, p. 976- 996, 2016. Disponível em: < http://dx.doi.org/10.1111/tra.12412 > DOI: 10.1111/tra.12412.
APA
Pereira, E. A., & Silva, L. L. P. da. (2016). HIV-1 Nef: taking control of protein trafficking. Traffic, 17, 976- 996. doi:10.1111/tra.12412
NLM
Pereira EA, Silva LLP da. HIV-1 Nef: taking control of protein trafficking [Internet]. Traffic. 2016 ; 17 976- 996.Available from: http://dx.doi.org/10.1111/tra.12412
Vancouver
Pereira EA, Silva LLP da. HIV-1 Nef: taking control of protein trafficking [Internet]. Traffic. 2016 ; 17 976- 996.Available from: http://dx.doi.org/10.1111/tra.12412
Artigo de periodico
Pharmacological beta-adrenergic receptor activation attenuates neutrophil recruitment by a mechanism dependent on nicotinic receptor and the spleen (2016)
Silva, Rangel L.; Castanheira, Fernanda V.; Figueiredo, Jozi G.; Bassi, Gabriel S.; Ferreira, Sérgio Henrique; Cunha, Fernando de Queiroz; Cunha, Thiago Mattar; Kanashiro, Alexandre
Source: Inflammation. Unidade: FMRP
Subjects: ANTAGONISMO DE DROGAS, LEUCÓCITOS, NEUTRÓFILOS, RECEPTORES ADRENÉRGICOS, BAÇO, NEUROIMUNOMODULAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Rangel L.; CASTANHEIRA, Fernanda V.; FIGUEIREDO, Jozi G.; et al. Pharmacological beta-adrenergic receptor activation attenuates neutrophil recruitment by a mechanism dependent on nicotinic receptor and the spleen. Inflammation, New York, v. 39, n. 4, p. 1405-1413, 2016. Disponível em: < http://dx.doi.org/10.1007/s10753-016-0372-9 > DOI: 10.1007/s10753-016-0372-9.
APA
Silva, R. L., Castanheira, F. V., Figueiredo, J. G., Bassi, G. S., Ferreira, S. H., Cunha, F. de Q., et al. (2016). Pharmacological beta-adrenergic receptor activation attenuates neutrophil recruitment by a mechanism dependent on nicotinic receptor and the spleen. Inflammation, 39( 4), 1405-1413. doi:10.1007/s10753-016-0372-9
NLM
Silva RL, Castanheira FV, Figueiredo JG, Bassi GS, Ferreira SH, Cunha F de Q, Cunha TM, Kanashiro A. Pharmacological beta-adrenergic receptor activation attenuates neutrophil recruitment by a mechanism dependent on nicotinic receptor and the spleen [Internet]. Inflammation. 2016 ; 39( 4): 1405-1413.Available from: http://dx.doi.org/10.1007/s10753-016-0372-9
Vancouver
Silva RL, Castanheira FV, Figueiredo JG, Bassi GS, Ferreira SH, Cunha F de Q, Cunha TM, Kanashiro A. Pharmacological beta-adrenergic receptor activation attenuates neutrophil recruitment by a mechanism dependent on nicotinic receptor and the spleen [Internet]. Inflammation. 2016 ; 39( 4): 1405-1413.Available from: http://dx.doi.org/10.1007/s10753-016-0372-9
Artigo de periodico
Purinergic receptors in the carotid body as a new drug target for controlling hypertension (2016)
Pijacka, Wioletta; Moraes, Davi José de Almeida; Ratcliffe, Laura E. K.; Nightingale, Angus; Hart, Emma C.; Silva, Melina P. da; Machado, Benedito Honório; McBryde, Fiona D.; Abdala, Ana P.; Ford, Anthony P.; Paton, Julian F. R.
Source: Nature Medicine. Unidade: FMRP
Subjects: HIPERTENSÃO, RECEPTORES, ANTAGONISMO DE DROGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PIJACKA, Wioletta; MORAES, Davi José de Almeida; RATCLIFFE, Laura E. K.; et al. Purinergic receptors in the carotid body as a new drug target for controlling hypertension. Nature Medicine, New York, v. 22, n. 10, p. 1151-1159, 2016. Disponível em: < http://dx.doi.org/10.1038/nm.4173 > DOI: 10.1038/nm.4173.
APA
Pijacka, W., Moraes, D. J. de A., Ratcliffe, L. E. K., Nightingale, A., Hart, E. C., Silva, M. P. da, et al. (2016). Purinergic receptors in the carotid body as a new drug target for controlling hypertension. Nature Medicine, 22( 10), 1151-1159. doi:10.1038/nm.4173
NLM
Pijacka W, Moraes DJ de A, Ratcliffe LEK, Nightingale A, Hart EC, Silva MP da, Machado BH, McBryde FD, Abdala AP, Ford AP, Paton JFR. Purinergic receptors in the carotid body as a new drug target for controlling hypertension [Internet]. Nature Medicine. 2016 ; 22( 10): 1151-1159.Available from: http://dx.doi.org/10.1038/nm.4173
Vancouver
Pijacka W, Moraes DJ de A, Ratcliffe LEK, Nightingale A, Hart EC, Silva MP da, Machado BH, McBryde FD, Abdala AP, Ford AP, Paton JFR. Purinergic receptors in the carotid body as a new drug target for controlling hypertension [Internet]. Nature Medicine. 2016 ; 22( 10): 1151-1159.Available from: http://dx.doi.org/10.1038/nm.4173
Trabalho de evento-resumo periodico
Oral naltrexone as an adjuvant therapy for refractory atopic dermatitis (2015)
Tirico, Maria Claudia; Samorano, Luciana Paula; Orfali, Raquel Leao; Aoki, Valeria
Source: Journal of the American Academy of dermatology. Conference titles: Annual Meeting of the American Academy of Dermatology. Unidade: FM
Subjects: DERMATITE, SISTEMA NERVOSO CENTRAL, SINAIS E SINTOMAS, USOS TERAPÊUTICOS, ANTAGONISMO DE DROGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TIRICO, Maria Claudia; SAMORANO, Luciana Paula; ORFALI, Raquel Leao; AOKI, Valeria. Oral naltrexone as an adjuvant therapy for refractory atopic dermatitis. Journal of the American Academy of dermatology[S.l: s.n.], 2015.Disponível em: .
APA
Tirico, M. C., Samorano, L. P., Orfali, R. L., & Aoki, V. (2015). Oral naltrexone as an adjuvant therapy for refractory atopic dermatitis. Journal of the American Academy of dermatology. California. Recuperado de http://www.sciencedirect.com/science/article/pii/S0190962215004272
NLM
Tirico MC, Samorano LP, Orfali RL, Aoki V. Oral naltrexone as an adjuvant therapy for refractory atopic dermatitis [Internet]. Journal of the American Academy of dermatology. 2015 ; 72( 5): AB75.Available from: http://www.sciencedirect.com/science/article/pii/S0190962215004272
Vancouver
Tirico MC, Samorano LP, Orfali RL, Aoki V. Oral naltrexone as an adjuvant therapy for refractory atopic dermatitis [Internet]. Journal of the American Academy of dermatology. 2015 ; 72( 5): AB75.Available from: http://www.sciencedirect.com/science/article/pii/S0190962215004272
Artigo de periodico
Nociceptive vocalization response in guinea pigs modulated by opioidergic, GABAergic and serotonergic neurotransmission in the dorsal raphe nucleus (2014)
Ferreira, Mateus Dalbem; Menescal-de-Oliveira, Leda
Source: Brain Research Bulletin. Unidade: FMRP
Subjects: ANALGÉSICOS (FARMACOLOGIA), ANTAGONISMO DE DROGAS, GABA, NOCICEPTORES, SEROTONINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Mateus Dalbem; MENESCAL-DE-OLIVEIRA, Leda. Nociceptive vocalization response in guinea pigs modulated by opioidergic, GABAergic and serotonergic neurotransmission in the dorsal raphe nucleus. Brain Research Bulletin, Philadelphia, v. 106, p. 21-29, 2014. Disponível em: < http://dx.doi.org/10.1016/j.brainresbull.2014.05.001 > DOI: 10.1016/j.brainresbull.2014.05.001.
APA
Ferreira, M. D., & Menescal-de-Oliveira, L. (2014). Nociceptive vocalization response in guinea pigs modulated by opioidergic, GABAergic and serotonergic neurotransmission in the dorsal raphe nucleus. Brain Research Bulletin, 106, 21-29. doi:10.1016/j.brainresbull.2014.05.001
NLM
Ferreira MD, Menescal-de-Oliveira L. Nociceptive vocalization response in guinea pigs modulated by opioidergic, GABAergic and serotonergic neurotransmission in the dorsal raphe nucleus [Internet]. Brain Research Bulletin. 2014 ; 106 21-29.Available from: http://dx.doi.org/10.1016/j.brainresbull.2014.05.001
Vancouver
Ferreira MD, Menescal-de-Oliveira L. Nociceptive vocalization response in guinea pigs modulated by opioidergic, GABAergic and serotonergic neurotransmission in the dorsal raphe nucleus [Internet]. Brain Research Bulletin. 2014 ; 106 21-29.Available from: http://dx.doi.org/10.1016/j.brainresbull.2014.05.001
Artigo de periodico
Treatment of uncommon sites of focal primary hyperhidrosis: experience with pharmacological therapy using oxybutynin (2014)
Teivelis, Marcelo Passos; Wolosker, Nelson; Krutman, Mariana; Kauffman, Paulo; de Campos, José Ribas Milanez; Puech-Leão, Pedro
Source: Clinics. Unidade: FM
Subjects: FARMACOLOGIA, HIPERIDROSE (TERAPIA), ANTAGONISMO DE DROGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TEIVELIS, Marcelo Passos; WOLOSKER, Nelson; KRUTMAN, Mariana; et al. Treatment of uncommon sites of focal primary hyperhidrosis: experience with pharmacological therapy using oxybutynin. Clinics, São Paulo, v. 69, n. 9, p. 608-614, 2014. Disponível em: < http://www.scielo.br/pdf/clin/v69n9/1807-5932-clin-69-09-608.pdf > DOI: 10.6061/clinics/2014(09)06.
APA
Teivelis, M. P., Wolosker, N., Krutman, M., Kauffman, P., de Campos, J. R. M., & Puech-Leão, P. (2014). Treatment of uncommon sites of focal primary hyperhidrosis: experience with pharmacological therapy using oxybutynin. Clinics, 69( 9), 608-614. doi:10.6061/clinics/2014(09)06
NLM
Teivelis MP, Wolosker N, Krutman M, Kauffman P, de Campos JRM, Puech-Leão P. Treatment of uncommon sites of focal primary hyperhidrosis: experience with pharmacological therapy using oxybutynin [Internet]. Clinics. 2014 ; 69( 9): 608-614.Available from: http://www.scielo.br/pdf/clin/v69n9/1807-5932-clin-69-09-608.pdf
Vancouver
Teivelis MP, Wolosker N, Krutman M, Kauffman P, de Campos JRM, Puech-Leão P. Treatment of uncommon sites of focal primary hyperhidrosis: experience with pharmacological therapy using oxybutynin [Internet]. Clinics. 2014 ; 69( 9): 608-614.Available from: http://www.scielo.br/pdf/clin/v69n9/1807-5932-clin-69-09-608.pdf
Artigo de periodico
Both 'alfa'1- and 'alfa'2-adrenoceptors in the insular cortex are involved in the cardiovascular responses to acute restraint stress in rats (2014)
Alves, Fernando H. F; Crestani, Carlos C; Resstel, Leonardo Barbosa Moraes; Corrêa, Fernando Morgan de Aguiar
Source: PLOS ONE. Unidade: FMRP
Subjects: ANTAGONISMO DE DROGAS, CÓRTEX CEREBRAL (METABOLISMO), FREQUÊNCIA CARDÍACA (EFEITOS DE DROGAS), RECEPTORES ADRENÉRGICOS, ESTRESSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALVES, Fernando H. F; CRESTANI, Carlos C; RESSTEL, Leonardo Barbosa Moraes; CORRÊA, Fernando Morgan de Aguiar. Both 'alfa'1- and 'alfa'2-adrenoceptors in the insular cortex are involved in the cardiovascular responses to acute restraint stress in rats. PLOS ONE, San Francisco, v. 9, n. 1, p. e83900-1 - e83900-7, 2014. Disponível em: < http://dx.doi.org/10.1371/journal.pone.0083900 > DOI: 10.1371/journal.pone.0083900.
APA
Alves, F. H. F., Crestani, C. C., Resstel, L. B. M., & Corrêa, F. M. de A. (2014). Both 'alfa'1- and 'alfa'2-adrenoceptors in the insular cortex are involved in the cardiovascular responses to acute restraint stress in rats. PLOS ONE, 9( 1), e83900-1 - e83900-7. doi:10.1371/journal.pone.0083900
NLM
Alves FHF, Crestani CC, Resstel LBM, Corrêa FM de A. Both 'alfa'1- and 'alfa'2-adrenoceptors in the insular cortex are involved in the cardiovascular responses to acute restraint stress in rats [Internet]. PLOS ONE. 2014 ; 9( 1): e83900-1 - e83900-7.Available from: http://dx.doi.org/10.1371/journal.pone.0083900
Vancouver
Alves FHF, Crestani CC, Resstel LBM, Corrêa FM de A. Both 'alfa'1- and 'alfa'2-adrenoceptors in the insular cortex are involved in the cardiovascular responses to acute restraint stress in rats [Internet]. PLOS ONE. 2014 ; 9( 1): e83900-1 - e83900-7.Available from: http://dx.doi.org/10.1371/journal.pone.0083900
Artigo de periodico
NMDA receptor blockade impairs the muscarinic conversion of sub-threshold transient depression into long-lasting LTD in the hippocampus-prefrontal cortex pathway in vivo (2013)
Lopes-Aguiar, Cleiton; Bueno-Júnior, Lezio Soares; Ruggiero, Rafael Naime; Romcy-Pereira, Rodrigo Neves; Leite, João Pereira
Source: Neuropharmacology. Unidade: FMRP
Subjects: HIPOCAMPU DE ANIMAL (FISIOLOGIA;EFEITOS DE DROGAS), ANTAGONISMO DE DROGAS, PLASTICIDADE NEURONAL, CÓRTEX PRÉ-FRONTAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOPES-AGUIAR, Cleiton; BUENO-JÚNIOR, Lezio Soares; RUGGIERO, Rafael Naime; ROMCY-PEREIRA, Rodrigo Neves; LEITE, João Pereira. NMDA receptor blockade impairs the muscarinic conversion of sub-threshold transient depression into long-lasting LTD in the hippocampus-prefrontal cortex pathway in vivo. Neuropharmacology, Kidlington, v. 65, p. 143-155, 2013. Disponível em: < http://dx.doi.org/10.1016/j.neuropharm.2012.09.013 >.
APA
Lopes-Aguiar, C., Bueno-Júnior, L. S., Ruggiero, R. N., Romcy-Pereira, R. N., & Leite, J. P. (2013). NMDA receptor blockade impairs the muscarinic conversion of sub-threshold transient depression into long-lasting LTD in the hippocampus-prefrontal cortex pathway in vivo. Neuropharmacology, 65, 143-155. Recuperado de http://dx.doi.org/10.1016/j.neuropharm.2012.09.013
NLM
Lopes-Aguiar C, Bueno-Júnior LS, Ruggiero RN, Romcy-Pereira RN, Leite JP. NMDA receptor blockade impairs the muscarinic conversion of sub-threshold transient depression into long-lasting LTD in the hippocampus-prefrontal cortex pathway in vivo [Internet]. Neuropharmacology. 2013 ; 65 143-155.Available from: http://dx.doi.org/10.1016/j.neuropharm.2012.09.013
Vancouver
Lopes-Aguiar C, Bueno-Júnior LS, Ruggiero RN, Romcy-Pereira RN, Leite JP. NMDA receptor blockade impairs the muscarinic conversion of sub-threshold transient depression into long-lasting LTD in the hippocampus-prefrontal cortex pathway in vivo [Internet]. Neuropharmacology. 2013 ; 65 143-155.Available from: http://dx.doi.org/10.1016/j.neuropharm.2012.09.013
Artigo de periodico
Antagonism of the transient receptor potential ankyrin 1 (TRPA1) attenuates hyperalgesia and urinary bladder overactivity in cyclophosphamide-induced haemorrhagic cystitis (2013)
Meotti, Flavia Carla ; Forner, Stefânia; Lima-Garcia, Juliana F; Viana, Alice Fialho; Calixto, João Batista
Source: Chemico-Biological Interactions. Unidade: IQ
Subjects: ANTAGONISMO DE DROGAS, BIOQUÍMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEOTTI, Flavia Carla; FORNER, Stefânia; LIMA-GARCIA, Juliana F; VIANA, Alice Fialho; CALIXTO, João Batista. Antagonism of the transient receptor potential ankyrin 1 (TRPA1) attenuates hyperalgesia and urinary bladder overactivity in cyclophosphamide-induced haemorrhagic cystitis. Chemico-Biological Interactions, Clare, v. 203, n. 2, p. 440-447, 2013. Disponível em: < http://dx.doi.org/10.1016/j.cbi.2013.03.008 > DOI: 10.1016/j.cbi.2013.03.008.
APA
Meotti, F. C., Forner, S., Lima-Garcia, J. F., Viana, A. F., & Calixto, J. B. (2013). Antagonism of the transient receptor potential ankyrin 1 (TRPA1) attenuates hyperalgesia and urinary bladder overactivity in cyclophosphamide-induced haemorrhagic cystitis. Chemico-Biological Interactions, 203( 2), 440-447. doi:10.1016/j.cbi.2013.03.008
NLM
Meotti FC, Forner S, Lima-Garcia JF, Viana AF, Calixto JB. Antagonism of the transient receptor potential ankyrin 1 (TRPA1) attenuates hyperalgesia and urinary bladder overactivity in cyclophosphamide-induced haemorrhagic cystitis [Internet]. Chemico-Biological Interactions. 2013 ; 203( 2): 440-447.Available from: http://dx.doi.org/10.1016/j.cbi.2013.03.008
Vancouver
Meotti FC, Forner S, Lima-Garcia JF, Viana AF, Calixto JB. Antagonism of the transient receptor potential ankyrin 1 (TRPA1) attenuates hyperalgesia and urinary bladder overactivity in cyclophosphamide-induced haemorrhagic cystitis [Internet]. Chemico-Biological Interactions. 2013 ; 203( 2): 440-447.Available from: http://dx.doi.org/10.1016/j.cbi.2013.03.008
Artigo de periodico
Tolerance to hypophagia induced by prolonged treatment with a CB1 antagonist is related to the reversion of anorexigenic neuropeptide gene expression in the hypothalamus (2013)
Rorato, Rodrigo; Miyahara, Cristiano; Antunes-Rodrigues, José; Elias, Lucila Leico Kagohara
Source: Regulatory Peptides. Unidade: FMRP
Subjects: ANOREXIA, PESOS E MEDIDAS CORPORAIS (EFEITOS DE DROGAS), HIPOTÁLAMO, NEUROPEPTÍDEOS, ANTAGONISMO DE DROGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RORATO, Rodrigo; MIYAHARA, Cristiano; ANTUNES-RODRIGUES, José; ELIAS, Lucila Leico Kagohara. Tolerance to hypophagia induced by prolonged treatment with a CB1 antagonist is related to the reversion of anorexigenic neuropeptide gene expression in the hypothalamus. Regulatory Peptides, Amsterdam, v. 182, p. 12-18, 2013. Disponível em: < http://dx.doi.org/10.1016/j.regpep.2012.12.004 > DOI: 10.1016/j.regpep.2012.12.004.
APA
Rorato, R., Miyahara, C., Antunes-Rodrigues, J., & Elias, L. L. K. (2013). Tolerance to hypophagia induced by prolonged treatment with a CB1 antagonist is related to the reversion of anorexigenic neuropeptide gene expression in the hypothalamus. Regulatory Peptides, 182, 12-18. doi:10.1016/j.regpep.2012.12.004
NLM
Rorato R, Miyahara C, Antunes-Rodrigues J, Elias LLK. Tolerance to hypophagia induced by prolonged treatment with a CB1 antagonist is related to the reversion of anorexigenic neuropeptide gene expression in the hypothalamus [Internet]. Regulatory Peptides. 2013 ; 182 12-18.Available from: http://dx.doi.org/10.1016/j.regpep.2012.12.004
Vancouver
Rorato R, Miyahara C, Antunes-Rodrigues J, Elias LLK. Tolerance to hypophagia induced by prolonged treatment with a CB1 antagonist is related to the reversion of anorexigenic neuropeptide gene expression in the hypothalamus [Internet]. Regulatory Peptides. 2013 ; 182 12-18.Available from: http://dx.doi.org/10.1016/j.regpep.2012.12.004

ReP

Filtros

Vocabulário Controlado do SIBiUSP

USP Schools

ReP

Filtros

Document Types

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Countries/Territories

Funding Agencies

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration

Sigla do Departamento/Programa de Pós Graduação

Keywords

Vocabulário Controlado do SIBiUSP